NRG4 and colitis: To test if replacing NRG4 during colitis therapeutically alters the macrophage population, mice were given DSS to establish colitis, and then were treated with daily intraperitoneal injections of NRG4 (100 μg/kg) between days 4 and 7, the period of maximal macrophage influx (Figure 5b).